>
pdufa.bio

ARV-471

Updated ยทnext FDA decision on the calendar

ARV-471 is a Arvinas, Inc. program. Its next catalyst is a Readout in Nov 2026. Every date links its source.

ARVN catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Arvinas, Inc. (ARVN). We track 3 catalyst events for this program: 3 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Nov 2026ARVNReadout · Dec 2026ARVNReadout · Mar 2027ARVN

Questions

When is ARV-471's next FDA decision or readout?

The next tracked catalyst for ARV-471 is a Readout in Nov 2026.

What happened at ARV-471's most recent FDA decision?

No FDA decision for ARV-471 is in our archive yet.

Who makes ARV-471?

Arvinas, Inc. (ARVN).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.